A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Multicenter Study of Buntanetap in Participants with Mild to Moderate Alzheimer's Disease
Clinical Trial Grant
Administered By
Neurology, Behavioral Neurology
Awarded By
DCRI-Duke-Site
Start Date
April 11, 2023
End Date
December 31, 2026
Administered By
Neurology, Behavioral Neurology
Awarded By
DCRI-Duke-Site
Start Date
April 11, 2023
End Date
December 31, 2026